Trontinemab, utilizing Roche’s Brainshuttle technology, boosts drug delivery across the blood-brain barrier, driving robust ...

The startup’s lead prospect stabilizes abnormal proteins in patients with amyloid “light chain” amyloidosis, an approach that ...

HealthDay News — Faster amyloid accumulation is seen over time among individuals with obesity, according to a study presented at the annual meeting of the Radiological Society of North America, held ...

Almost four years after penning its first amyloidosis collaboration with Neurimmune, AstraZeneca has returned to ...

More than nine in 10 patients treated with Roche’s next-generation Alzheimer’s disease antibody trontinemab tested negative for amyloid plaques in a mid-stage study, marking a return to the ...

The advent of amyloid-β (Aβ) and tau PET imaging has revolutionized Alzheimer disease (AD) research, enabling in vivo ...

A new study finds that taking arginine orally may lower amyloid buildup and neuroinflammation, suggesting a safe, low-cost ...

Demonstrated brain imaging analysis solutions, including 'Neurophet AQUA AD,' which enables monitoring of adverse effects ...

There is no single, easy test to diagnose Alzheimer’s, but a new review of 18 scientific studies confirms that a simple blood ...

A Korean research team has identified the most effective OLED color capable of enhancing cognitive function in Alzheimer's ...

Transthyretin amyloid cardiomyopathy (ATTR-CM) may not have any symptoms. When symptoms do appear, they might include leg ...

Find out more about how dementia biomarkers in blood tests can predict early cognitive decline and disease progression.